Friday, March 12, 2010
"The source for European pharmaceutical biotechnology news..."
Sponsors
Platinum Sponsors
Blog
Where our team of editors discuss what they think about the current NGP US Issues.
Marie Shields
Editor NGP Europe
Editor NGP Europe
Tough competition
The battle between generics and branded products has been going on for a long time: the claims and counter claims over Aspirin, for example, have been in process since the early 20th century.05 Aug 2009
Focus Areas
Cover Stories
Standing out from the crowd
Mike Cola and Sylvie Gregoire of Shire Pharmaceuticals explain why being different is increasingly important in the dark days of economic...
Riding the wave
The global pharmaceutical industry is facing some tough challenges at the moment: patent expiries, a lack of new blockbusters, and now the...
Sink or swim
The global financial crisis has prompted a rash of mergers, consolidations and layoffs in the pharmaceutical sector. Will the European...
Roundtables
-
Making informed decisions
Using informatics solutions to manage data in the drug discovery process. With STARLIMS Corporation and TeraDiscRead more -
Meeting the challenges of supply chain reg...
NGP speaks to two experts about the changes affecting the pharmaceutical cold chain. With Jean Bédard, Alternatives Technologie Pharma Inc. and Richard Harrop of SCA Cool...Read more -
The advantages of outsourcing
Optimising your resources to achieve long-term success. With Grindeks’ Lipmans Zeligmans, Anders Ulfhielm of Rechon Life Science AB and Jim Kernan of PharmaFlow LtdRead more
Vendor Perspectives
-
Industrial IT eXtended process automatio...
ABB’s next generation PAT application leverages its System 800xA environment to simplify engineering and integration with enterprise systems.Read more -
Drug repositioning – a key tool in the d...
Drug development pipelines have been a major indicator of the health of the pharmaceutical industry itslef. However if we look at recent trends, the simple truth is that...Read more -
Competence for solid forms
Dragenopharm is a global contract manufacturer for solid forms in the pharmaceutical and the health care section with headquarters in Tittmoning.Read more -
Imaging is key to success in oncology tr...
As defined by the NCI, "Translational research transforms scientific discoveries arising from laboratory, clinical, or population studies into clinical applications to...Read more -
Combined competence to serve the pharmac...
Bürkert Fluid Control Systems and BBS Systems combine to make one of the most comprehensive partnerships in the hygienic processing segment.Read more
Industry Analysts
-
Knocking on a difficult door
As payors gain increasing power over access to medicines, Justin van Gennep of Innovex examines their particular priorities and explores how to address their needs for the...Read more -
A new model for drug discovery
The productivity crisis in pharmaceutical drug discovery, or ‘innovation gap’ as it has been coined, is well recognised and the subject of much debate in the industry and...Read more -
A new PET imaging agent
A new imaging agent, 64Cu-DOTA-bevacizumab, has been developed for scanning of tumor growth and functional imaging of angiogenesis in animal tumor models. By MPI ResearchRead more -
A revolution in personalised medicine
The pharmaceutical market is changing fast and industry has been required to move quickly to keep pace with this dynamic situation. By Randox LaboratoriesRead more -
Six risks to intellectual property
While partnerships play an increasingly critical role in the drug development lifecycle, a poorly structured partnership can expose your intellectual property (IP) to...Read more -
Cross-divisional integrated solutions
The supply chain has become a competitive edge, a sales argument and at the same time, a key area for cost cutting activities. Time to market plays a significant role for...Read more
Executive Interviews
Tools for screening and validation
Taqman SNP Genotyping Assays, developed by Applied Biosystems, are a state-of-the-art technology for screening and validation of polymorphisms. Recently Applied Biosystems introduced two new products to complement this offering; the high throughpu...
Read more
The future of drug repositioning
Andreas Persidis of Biovista talks to NGP about the transformational potential of drug repositioning.
Read more
NGP Europe Summit: Drug Discovery
1st - 3rd September 2010
The Next Generation Drug Discovery Summit Europe is designed to bridge the growing technological gap between drug discovery and drug development.
Source: www.ngpharma.eu.com© 2010 GDS Publishing Ltd. All rights reserved.